Pharming Group N.V. (AMS:PHARM)
0.8460
-0.0142 (-1.65%)
Oct 15, 2026, 3:38 PM CET
Pharming Group Employees
Pharming Group had 407 employees as of December 31, 2025. The number of employees increased by 3 or 0.74% compared to the previous year. That makes Pharming Group the 21,586th largest employer in the world and 73rd in the Netherlands.
Employees
407
Change (1Y)
3
Growth (1Y)
0.74%
Revenue / Employee
€788,155
Profits / Employee
€20,003
Market Cap
598.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 407 | 3 | 0.74% |
| Dec 31, 2024 | 404 | 22 | 5.76% |
| Dec 31, 2023 | 382 | 50 | 15.06% |
| Dec 31, 2022 | 332 | 55 | 19.86% |
| Dec 31, 2021 | 277 | 15 | 5.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PostNL | 31,531 |
| Fugro | 10,000 |
| Sligro Food Group | 4,375 |
| TomTom | 3,300 |
| ForFarmers | 2,854 |
| Ferrari Group | 2,173 |
| Triodos Bank | 1,895 |
| Acomo | 1,330 |
Pharming Group News
- 1 day ago - Pharming's Leniolisib Shows Promise Beyond APDS In Rare Genetic Immune Disorders - Nasdaq
- 1 day ago - Pharming Reports Positive Phase II Data For Leniolisib In Rare Genetic Immune Disorders - Nasdaq
- 1 day ago - Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026 - GlobeNewsWire
- 16 days ago - Pharming (PHAR) CEO Departure and Interim Leadership Amid Modest Undervaluation - GuruFocus
- 16 days ago - Pharming announces CEO Fabrice Chouraqui to step down - TheFly
- 16 days ago - Pharming announces CEO transition - GlobeNewsWire
- 19 days ago - FDA Accepts Pharming's SNDA For Lower-Dose Joenja In Children With APDS - Nasdaq
- 19 days ago - Pharming announces FDA acceptance, Priority review of sNDA for Joenja - TheFly